Compliance
The Food and Drug Administration approved a naloxone hydrochloride nasal spray to treat opioid overdoses that delivers 8 milligrams of naloxone, up from 2 mg or 4 mg in previously approved products.
The Centers for Medicare & Medicaid Services released a toolkit for qualified health plans applying for plan year 2022 certification, and guidance to help applicants identify essential community providers and meet network adequacy standards.
New information sharing requirements for health information technology take effect April 5 under an interim final rule released last year by the Office of the National Coordinator for Health Information Technology.
The Department of Homeland Security formally removed its public charge rule from the Code of Federal Regulations.
The Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology should extend the deadline to comply with its final rule implementing information blocking provisions of the 21st Century Cures Act to 2022 or six months after the end of the COVID-19…
The Centers for Medicare & Medicaid Services said that will audit a sample of hospitals in January for compliance with the agency’s hospital price transparency rule that takes effect Jan. 1, 2021.
The Centers for Medicare & Medicaid Services seeks comments through Feb. 16 on a proposed Review Choice demonstration for inpatient rehabilitation facilities, which seeks to improve methods to investigate and prosecute Medicare fraud.
The Drug Enforcement Administration published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.
The AHA responded to a Centers for Medicare…
The Centers for Medicare…